Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
308,713,740
-
Number of holders
-
269
-
Total 13F shares, excl. options
-
319,344,550
-
Shares change
-
+9,863,634
-
Total reported value, excl. options
-
$1,830,820,509
-
Value change
-
+$26,198,234
-
Put/Call ratio
-
63%
-
Number of buys
-
150
-
Number of sells
-
-129
-
Price
-
$5.73
Significant Holders of AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) as of Q2 2025
334 filings reported holding FOLD - AMICUS THERAPEUTICS, INC. - Common Stock as of Q2 2025.
AMICUS THERAPEUTICS, INC. - Common Stock (FOLD) has 269 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 319,344,550 shares
.
Largest 10 shareholders include VANGUARD GROUP INC (29,407,588 shares), WELLINGTON MANAGEMENT GROUP LLP (29,123,962 shares), BlackRock, Inc. (27,532,209 shares), Avoro Capital Advisors LLC (18,000,000 shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (14,642,157 shares), Vestal Point Capital, LP (11,900,000 shares), STATE STREET CORP (11,568,097 shares), MACQUARIE GROUP LTD (7,722,318 shares), MILLENNIUM MANAGEMENT LLC (7,421,640 shares), and PERCEPTIVE ADVISORS LLC (7,412,830 shares).
This table shows the top 269 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.